5 comments

[ 1.7 ms ] story [ 22.2 ms ] thread
I thought this was already done? What’s the innovation here?
PGT-A only screens for large chromosomal defects, not genetic variants (which is the cause of most genetic disease).
If you have a specific genetic defect in mind though you can create a specific probe to test for it. I guess this startup is eliminating that need and can screen generally
Gattaca incoming.
I’m doing the more basic one. Chromosomal, not this startup. All covered by insurance. It’s an interesting shift. I get to choose which embryo too which means choosing sex to some degree.

Amused that the promo picture shows “30x” embryos. That’s kind of absurd.